pipette
ESEspañol

Dengue virus controlled human challenge reveals that preexisting immunity shapes viral replication and broadly protective responses

Camila D. Odio, Rosemary A. Aogo, Saba Firdous, Charlie J. Voirin, Silvia Blanco, Kelsey Elizabeth Lowman, Nhyira Asante, Ysabelle Broderson, Keerthi Konda, Chloe M. Hasund, Amparo Martínez-Pérez, Patrick I. Mpingabo, Melissa A. Law, Caitlin Jarvis, Viviane Callier, Sally Hunsberger, María Abad-Fernández, Aravinda M. de Silva, Robbie Kattappuram, Gitanjali L. Bhushan, Christina Yek, Jessica E. Manning, Anna P. Durbin, Jeffrey I. Cohen, Daniela Weiskopf, Stephen S. Whitehead, Leah C. Katzelnick

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Together, these findings demonstrate that controlled human challenge with dengue virus can delineate coordinated versus dysregulated acute immune responses and their effects on immunogenicity, informing therapeutic and vaccine strategies for dengue and other viral diseases.

Appeared: Friday, October 30. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.aei5117